Get the Stockscreener App
24.18
0.66%
-0.16
Pre-market:
24.12
-0.06
-0.25%
Doximity Inc stock is traded at $24.18, with a volume of 2.05M.
It is down -0.66% in the last 24 hours and down -0.90% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$24.34
Open:
$24.62
24h Volume:
2.05M
Relative Volume:
0.61
Market Cap:
$4.47B
Revenue:
$637.78M
Net Income/Loss:
$239.40M
P/E Ratio:
20.30
EPS:
1.1909
Net Cash Flow:
$307.21M
1W Performance:
-2.46%
1M Performance:
-0.90%
6M Performance:
-67.49%
1Y Performance:
-63.40%
1-Day Range:
$23.53
$24.94
1-Week Range:
$23.53
$25.41
52-Week Range:
$23.53
$76.51
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.18 | 4.47B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
178.11 | 29.09B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.61B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.76 | 8.36B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.47 | 6.97B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity (NYSE:DOCS) Hits New 1-Year LowTime to Sell? - MarketBeat
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now? - TradingView
Doximity stock hits 52-week low at 23.53 USD - Investing.com
E. Ohman J or Asset Management AB Invests $24.70 Million in Doximity, Inc. $DOCS - MarketBeat
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - TradingView
Freedom Capital initiates Doximity (DOCS) with buy rating, $31 price target - MSN
Freedom Capital Initiates Doximity (DOCS) With Buy Rating, $31 Price Target - Insider Monkey
Doximity Inc. (NYSE:DOCS) Presents a Compelling Case for Growth at a Reasonable Price (GARP) Investors - ChartMill
Doximity (NYSE:DOCS) Upgraded to "Strong-Buy" at Freedom Capital - MarketBeat
The Bull Case For Doximity (DOCS) Could Change Following Surge In Physician AI Interest And Concerns - Sahm
Doximity (DOCS) Receives "Buy" Rating from Freedom Capital Marke - GuruFocus
Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS) - The Globe and Mail
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Physicians still concerned about AI accuracy amid rapid adoption: survey - Healthcare Dive
Doximity stock is collapsing after hours: Here's why - MSN
Freedom Capital Markets initiates coverage of Doximity (DOCS) with buy recommendation - MSN
A Look At Doximity’s Valuation After New Report On Rapid Physician AI Adoption - simplywall.st
Freedom Capital Markets initiates Doximity stock with buy rating By Investing.com - Investing.com Australia
Freedom Capital Markets initiates Doximity stock with buy rating - Investing.com
SEC files settled insider trading charges against former Chief Revenue Officer of Doximity - FX News Group
Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist - The AI Journal
Aquatic Capital Management Buys Doximity Shares - National Today
SEC Sues Ex-Doximity Exec Who Pleaded Guilty to Insider Trading - Bloomberg Law News
Iron Triangle Partners LP Sells 261,300 Shares of Doximity, Inc. - National Today
Iron Triangle Partners LP Sells 261,300 Shares of Doximity, Inc. $DOCS - MarketBeat
Integral Health Asset Management Buys Stake in Doximity - National Today
Assessing Doximity (DOCS) Valuation After A Steep Share Price Pullback - Yahoo Finance
Is Doximity (DOCS) Now Offering Value After A 61% One Year Share Price Slide - simplywall.st
Franklin Resources Boosts Stake in Doximity - National Today
Capital Fund Management S.A. Acquires 108,937 Shares of Doximity, Inc. $DOCS - MarketBeat
Franklin Resources Inc. Increases Stake in Doximity, Inc. $DOCS - MarketBeat
First Trust Advisors LP Lowers Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Doximity Insider Sells $58,833 in Stock - National Today
Doximity (NASDAQ:DOCS) Insider Sells $63,622.16 in Stock - MarketBeat
Insider Selling: Doximity (NASDAQ:DOCS) Insider Sells $58,833.03 in Stock - MarketBeat
Sitaram Siddharth sells Doximity shares worth $58,833 - Investing.com UK
Sitaram Siddharth sells Doximity shares worth $58,833 By Investing.com - Investing.com Nigeria
Doximity interim PFO Sitaram sells $63,622 in shares - Investing.com
Doximity interim PFO Sitaram sells $63,622 in shares By Investing.com - Investing.com Australia
Doximity (DOCS) interim PFO exercises 5,000 options, sell-to-cover 2,319 shares - Stock Titan
Doximity (DOCS) interim PFO exercises options, converts B to A, sells stock - Stock Titan
Capital World Investors Boosts Stake in Doximity - National Today
Capital World Investors Increases Position in Doximity, Inc. $DOCS - MarketBeat
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
American Century Companies Boosts Doximity Stake by 60% - National Today
American Century Companies Inc. Has $16.30 Million Position in Doximity, Inc. $DOCS - MarketBeat
What Analysts Are Saying About Doximity Stock - Sahm
Morgan Stanley Smith Barney files Rule 144 notice for DOCS (NYSE: DOCS) - Stock Titan
Doximity Stock is Down 75% From Its Highs. Do Analysts See Recovery? - TIKR.com
Doximity (NASDAQ:DOCS) Receives "Outperform" Rating from Royal Bank Of Canada - MarketBeat
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):